Elevated periprostatic venous testosterone correlates with prostate cancer progression after radical prostatectomy

被引:1
|
作者
Alyamani, Mohammad [1 ]
Michael, Patrick [1 ,2 ]
Hettel, Daniel [1 ,2 ]
Thomas, Lewis [1 ,2 ]
Lundy, Scott D. [2 ]
Berk, Mike [1 ]
Patel, Mona [1 ]
Li, Jianbo [3 ]
Rashidi, Hooman [4 ]
McKenney, Jesse K. [4 ]
Klein, Eric A. [1 ,2 ]
Sharifi, Nima [1 ,2 ,5 ,6 ]
机构
[1] Lerner Res Inst, Genitourinary Malignancies Res Ctr, Cleveland, OH USA
[2] Glickman Urol & Kidney Inst, Dept Urol, Cleveland, OH USA
[3] Lerner Res Inst, Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Cleveland Clin, Pathol & Lab Med Inst, Dept Pathol, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, Cleveland, OH USA
[6] Univ Miami, Miller Sch Med, Desai Sethi Urol Inst, Rosenstiel Med Sci Bldg,1600 NW 10th Ave,Room 602, Miami, FL 33136 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2023年 / 133卷 / 17期
关键词
SERUM; 17-HYDROXYPROGESTERONE; THERAPY; HYPOGONADISM; VARICOCELE; TISSUE; MEN;
D O I
10.1172/JCI171117
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
BACKGROUND. Generally, clinical assessment of gonadal testosterone (T) in human physiology is determined using concentrations measured in peripheral blood. Prostatic T exposure is similarly thought to be determined from peripheral T exposure. Despite the fact that androgens drive prostate cancer, peripheral T has had no role in the clinical evaluation or treatment of men with localized prostate cancer.METHODS. To assess the role of local androgen delivery in prostate cancer, we obtained blood from the (periprostatic) prostatic dorsal venous complex in 266 men undergoing radical prostatectomy from July 2014 to August 2021 and compared dorsal T (DT) levels with those in circulating peripheral blood (PT) and prostatic tissue. Comprehensive targeted steroid analysis and unbiased metabolomics analyses were performed. The association between the DT/PT ratio and progression-free survival after prostatectomy was assessed.RESULTS. Surprisingly, in some men, DT levels were enriched several-fold compared with PT levels. For example, 20% of men had local T concentrations that were at least 2-fold higher than peripheral T concentrations. Isocaproic acid, a byproduct of androgen biosynthesis, and 17-OH-progesterone, a marker of intratesticular T, were also enriched in the dorsal vein of these men, consistent with testicular shunting. Men with enriched DT had higher rates of prostate cancer recurrence. DT/PT concentration ratios predicted worse outcomes even when accounting for known clinical predictors.CONCLUSIONS. These data suggest that a large proportion of men have a previously unappreciated exposure to an undiluted and highly concentrated T supply. Elevated periprostatic T exposure was associated with worse clinical outcomes after radical prostatectomy. FUNDING. National Cancer Institute (NCI), NIH grants R01CA172382, R01CA236780, R01CA261995, R01CA249279, and R50CA251961; US Army Medical Research and Development Command grants W81XWH2010137 and W81XWH-22-1-0082.
引用
收藏
页数:9
相关论文
共 50 条
  • [32] The significance of extended lymph node dissection to progression and death in prostate cancer after radical prostatectomy
    Mansoori, Mehbod
    Ahlgren, Goran
    SCANDINAVIAN JOURNAL OF UROLOGY, 2019, 53 : 38 - 38
  • [33] Prognostic factors of prostate cancer systemic progression in patients with biochemical recurrence after radical prostatectomy
    Demeshko, P. D.
    Krasny, S. A.
    ONKOUROLOGIYA, 2013, 9 (01): : 62 - 67
  • [34] Salvage therapy for prostate cancer after radical prostatectomy
    Zaorsky, Nicholas G.
    Calais, Jeremie
    Fanti, Stefano
    Tilki, Derya
    Dorff, Tanya
    Spratt, Daniel E.
    Kishan, Amar U.
    NATURE REVIEWS UROLOGY, 2021, 18 (11) : 643 - 668
  • [35] Salvage therapy for prostate cancer after radical prostatectomy
    Nicholas G. Zaorsky
    Jeremie Calais
    Stefano Fanti
    Derya Tilki
    Tanya Dorff
    Daniel E. Spratt
    Amar U. Kishan
    Nature Reviews Urology, 2021, 18 : 643 - 668
  • [36] Adjuvant Radiotherapy after radical Prostatectomy for Prostate Cancer
    Schmidt, S.
    Zengerling, F.
    UROLOGE, 2015, 54 (07): : 1017 - 1020
  • [37] Anastomotic stricture after radical prostatectomy for prostate cancer
    Ouzaid, I.
    Lebeau, T.
    Richard, F.
    Chartier-Kastler, E.
    Bitker, M. -O.
    Thibault, F.
    PROGRES EN UROLOGIE, 2010, 20 (05): : 327 - 331
  • [38] Local recurrences after radical prostatectomy for prostate cancer
    Viville, C
    ANNALES D UROLOGIE, 2000, 34 (01) : 53 - 57
  • [39] Salvage radical prostatectomy after HIFU for prostate cancer
    Royce, P. L.
    Sothilingam, S.
    Pedersen, J.
    BJU INTERNATIONAL, 2008, 101 : 34 - 34
  • [40] Defining prostate cancer risk after radical prostatectomy
    Adamis, S.
    Varkaralcis, I. M.
    EJSO, 2014, 40 (05): : 496 - 504